Companies / Re-Vana
Re-Vana
Company
Re-Vana develops and delivers biodegradable ocular drug delivery systems for patients with sight-threatening diseases.
Re-Vana has 3 investors on file, among them Clarendon Fund Managers, ExSight Ventures and InFocus Capital Partners. Its site was last checked 13 Nov 2026: site answers.
Investors
3 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Re-Vana and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Clarendon Fund Managers adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/revanatx.com/investors
# also
GET /v1/companies/revanatx.com
GET /v1/companies/revanatx.com/news